Cary N. Robertson

A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone

Steven A. Rosenberg, Michael T. Lotze, Linda Muul et al. · New England Journal of Medicine · 1987 · 2.8K citations

Pharmacy, Immunology, Oncology +14

Genetic Risk and Carcinogen Exposure: a Common Inherited Defect of the Carcinogen-Metabolism Gene Glutathione S-Transferase M1 (GSTM1) That Increases Susceptibility to Bladder Cancer

Douglas A. Bell, Jack A. Taylor, David F. Paulson et al. · JNCI Journal of the National Cancer Institute · 1993 · 705 citations

Medicine, Genetics, Urology +17

Kidney Cancer

Robert J. Motzer, Neeraj Agarwal, Clair J. Beard et al. · Journal of the National Comprehensive Cancer Network · 2009 · 470 citations · Full text

Medicine, Oncology, Surgery +17

Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study.

Suzanne L. Topalian, D. Solomon, F. P. Avis et al. · Journal of Clinical Oncology · 1988 · 439 citations

Life Sciences, Immunology, Oncology +13

Satisfaction and Regret after Open Retropubic or Robot-Assisted Laparoscopic Radical Prostatectomy

Florian R. Schroeck, Tracey L. Krupski, Leon Sun et al. · European Urology · 2008 · 370 citations

Medicine, Surgery, Urology +14